Literature DB >> 9108083

Bruton's tyrosine kinase regulates apoptosis and JNK/SAPK kinase activity.

Y Kawakami1, T Miura, R Bissonnette, D Hata, W N Khan, T Kitamura, M Maeda-Yamamoto, S E Hartman, L Yao, F W Alt, T Kawakami.   

Abstract

Mast cells derived from Bruton's tyrosine kinase (Btk)-defective xid or btk null mice showed greater expansion in culture containing interleukin-3 (IL-3) than those from wild-type (wt) mice. Although the proliferative response to IL-3 was not significantly different between the wt and xid mast cells, xid and btk null mast cells died by apoptosis more slowly than their wt counterparts upon IL-3 deprivation. Consistent with these findings, the apoptosis-linked c-Jun N-terminal kinase/stress-activated protein kinase (JNK) activity was compromised in these btk-mutated cells upon Fc(epsilon)RI crosslinking or upon stimulation with IL-3 or with stem cell factor. p38 activity was less severely, but significantly, affected by btk mutation, whereas extracellular signal-regulated kinases were not affected by the same mutation. Btk-mediated regulation of apoptosis and JNK activity was confirmed by reconstitution of btk null mutant mast cells with the wt btk cDNA. Furthermore, growth factor withdrawal induced the activation and sustained activity of JNK in wt mast cells, while JNK activity was consistently lower in btk-mutated mast cells. These results support the notion that Btk regulates apoptosis through the JNK activation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9108083      PMCID: PMC20546          DOI: 10.1073/pnas.94.8.3938

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinases following B-cell antigen receptor surface engagement.

Authors:  S J Saouaf; S Mahajan; R B Rowley; S A Kut; J Fargnoli; A L Burkhardt; S Tsukada; O N Witte; J B Bolen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

2.  Defective B cell development and function in Btk-deficient mice.

Authors:  W N Khan; F W Alt; R M Gerstein; B A Malynn; I Larsson; G Rathbun; L Davidson; S Müller; A B Kantor; L A Herzenberg
Journal:  Immunity       Date:  1995-09       Impact factor: 31.745

3.  Impaired expansion of mouse B cell progenitors lacking Btk.

Authors:  J D Kerner; M W Appleby; R N Mohr; S Chien; D J Rawlings; C R Maliszewski; O N Witte; R M Perlmutter
Journal:  Immunity       Date:  1995-09       Impact factor: 31.745

4.  The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation.

Authors:  A B Raitano; J R Halpern; T M Hambuch; C L Sawyers
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

5.  Src family protein tyrosine kinases induce autoactivation of Bruton's tyrosine kinase.

Authors:  S Mahajan; J Fargnoli; A L Burkhardt; S A Kut; S J Saouaf; J B Bolen
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

6.  A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death.

Authors:  J Ham; C Babij; J Whitfield; C M Pfarr; D Lallemand; M Yaniv; L L Rubin
Journal:  Neuron       Date:  1995-05       Impact factor: 17.173

7.  Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre-B lymphocytes and receptor-ligated B cells.

Authors:  Y Aoki; K J Isselbacher; S Pillai
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

8.  Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.

Authors:  Z Xia; M Dickens; J Raingeaud; R J Davis; M E Greenberg
Journal:  Science       Date:  1995-11-24       Impact factor: 47.728

9.  ATF-2 contains a phosphorylation-dependent transcriptional activation domain.

Authors:  C Livingstone; G Patel; N Jones
Journal:  EMBO J       Date:  1995-04-18       Impact factor: 11.598

10.  ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents.

Authors:  H van Dam; D Wilhelm; I Herr; A Steffen; P Herrlich; P Angel
Journal:  EMBO J       Date:  1995-04-18       Impact factor: 11.598

View more
  25 in total

Review 1.  Prospects for the development of small molecular weight compounds to replace anti-tumour necrosis factor biological agents.

Authors:  B Foxwell; E Andreakos; F Brennan; M Feldmann; C Smith; M Conron
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

2.  Terreic acid, a quinone epoxide inhibitor of Bruton's tyrosine kinase.

Authors:  Y Kawakami; S E Hartman; E Kinoshita; H Suzuki; J Kitaura; L Yao; N Inagaki; A Franco; D Hata; M Maeda-Yamamoto; H Fukamachi; H Nagai; T Kawakami
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

3.  Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors.

Authors:  M I Wahl; A C Fluckiger; R M Kato; H Park; O N Witte; D J Rawlings
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

Review 4.  X-linked agammaglobulinemia: lack of mature B lineage cells caused by mutations in the Btk kinase.

Authors:  C I Smith; C M Bäckesjö; A Berglöf; L J Brandén; T Islam; P T Mattsson; A J Mohamed; S Müller; B Nore; M Vihinen
Journal:  Springer Semin Immunopathol       Date:  1998

5.  PKCbeta modulates antigen receptor signaling via regulation of Btk membrane localization.

Authors:  S W Kang; M I Wahl; J Chu; J Kitaura; Y Kawakami; R M Kato; R Tabuchi; A Tarakhovsky; T Kawakami; C W Turck; O N Witte; D J Rawlings
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

6.  A new c-Jun N-terminal kinase (JNK)-interacting protein, Sab (SH3BP5), associates with mitochondria.

Authors:  Carolyn Wiltshire; Masato Matsushita; Satoshi Tsukada; David A F Gillespie; Gerhard H W May
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

Review 7.  The tyrosine kinase network regulating mast cell activation.

Authors:  Alasdair M Gilfillan; Juan Rivera
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

8.  Unimpaired activation of c-Jun NH2-terminal kinase (JNK) 1 upon CD40 stimulation in B cells of patients with X-linked agammaglobulinemia.

Authors:  Cornelia Brunner; Hans Wolfgang Kreth; Hans D Ochs; Volker Schuster
Journal:  J Clin Immunol       Date:  2002-07       Impact factor: 8.317

9.  A Ras activation pathway dependent on Syk phosphorylation of protein kinase C.

Authors:  Yuko Kawakami; Jiro Kitaura; Libo Yao; Robert W McHenry; Yu Kawakami; Alexandra C Newton; Shin Kang; Roberta M Kato; Michael Leitges; David J Rawlings; Toshiaki Kawakami
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-24       Impact factor: 11.205

10.  Tec kinases regulate actin assembly and cytokine expression in LPS-stimulated human neutrophils via JNK activation.

Authors:  Rachel L Zemans; Patrick G Arndt
Journal:  Cell Immunol       Date:  2009-04-23       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.